Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/27/2025

Apixaban and Vitamin C Interactions

Introduction to Apixaban Metabolism

  • Apixaban is primarily metabolized via the liver through cytochrome P450 3A4 (CYP3A4) pathways, with renal elimination accounting for approximately 27% of total drug clearance 1
  • The main interaction mechanisms for apixaban involve P-glycoprotein (P-gp) transporter interactions and CYP3A4-dependent elimination 1

Drug-Drug Interactions with Apixaban

  • Significant drug-drug interactions with apixaban occur mainly through P-gp and CYP3A4 pathways, according to the European Heart Rhythm Association practical guide 2
  • Strong inhibitors of both CYP3A4 and P-gp should be used with caution or avoided with apixaban 2
  • Strong inducers of P-gp and/or CYP3A4 (such as rifampin, carbamazepine) should be avoided 2
  • Dose reduction of apixaban by 50% is recommended if used with strong CYP3A4 and P-gp inhibitors when on a regimen of 5-10 mg twice daily 1
  • Concomitant use is not recommended for patients already on the reduced dose of 2.5 mg twice daily 1

Vitamin C and Apixaban Interactions

  • Vitamin C is not known to be a significant inhibitor or inducer of either P-gp or CYP3A4 enzymes 2
  • There is no evidence that vitamin C inhibits or induces CYP3A4 enzymes, affects P-gp transport, alters the pharmacokinetics of apixaban, or increases bleeding risk when combined with apixaban 2
  • Unlike vitamin K, which directly interferes with the mechanism of action of warfarin, vitamin C does not have a known mechanism to interfere with factor Xa inhibition by apixaban 2

Patient Management

  • Monitor for bleeding signs, as with any patient on anticoagulation, regular assessment for bleeding signs is necessary 3
  • Maintain adherence, missing doses of apixaban is particularly problematic due to its short half-life (approximately 12 hours), potentially leaving patients unprotected 3
  • Periodic renal function monitoring is important for patients taking apixaban, especially in elderly patients 3
  • Patients with renal impairment should be more cautious with high-dose vitamin C supplements in general, as apixaban clearance is already affected by reduced renal function 2

Special Considerations

  • Standard doses of vitamin C as dietary supplements are unlikely to pose any risk 2
  • Extremely high doses of vitamin C (several grams daily) may cause gastrointestinal upset but are not known to interact with the anticoagulant effect of apixaban 2
  • Stopping apixaban abruptly should be avoided due to increased stroke risk 3